Showing results (201-210 of 319) with videos related to
Sort By:
Pageof 32
The American Journal of Psychiatry|September 1, 1987
Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary studyP J Weiden, J J Mann, G Haas, et al.Journal of Personality Assessment|February 1, 1985
Discriminant validity of the MMPI for borderline personality disorderS W Hurt, J F Clarkin, A Frances, et al.Psychiatry Research|August 1, 1988
Social functioning in chronic depression: effect of 6 weeks of antidepressant treatmentJ W Stewart, F M Quitkin, P J McGrath, et al.The American Journal of Psychiatry|September 1, 1984
Reliability of criteria for borderline personality disorder: a comparison of DSM-III and the Diagnostic Interview for Borderline PatientsA Frances, J F Clarkin, M Gilmore, et al.Psychiatric Services (Washington, D.C.)|October 1, 1995
Postdischarge medication compliance of inpatients converted from an oral to a depot neuroleptic regimenP Weiden, B Rapkin, A Zygmunt, et al.Psychosomatic Medicine|March 1, 1988
The mitral valve prolapse--panic disorder connectionJ M Gorman, R R Goetz, M Fyer, et al.The Journal of Clinical Psychiatry|August 1, 1992
Serotonergic medications for sexual obsessions, sexual addictions, and paraphiliasD J Stein, E Hollander, D T Anthony, et al.Archives of General Psychiatry|November 1, 1986
Blood gas changes and hypophosphatemia in lactate-induced panicJ M Gorman, B S Cohen, M R Liebowitz, et al.Psychiatry Research|January 1, 1991
Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorderE Hollander, C DeCaria, R Gully, et al.Archives of General Psychiatry|October 23, 1998
Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled studyB A Fallon, M R Liebowitz, R Campeas, et al.Pageof 32